Inflammation

, Volume 34, Issue 4, pp 238–246

Suppressive Effects of Procaterol on Expression of IP-10/CXCL 10 and RANTES/CCL 5 by Bronchial Epithelial Cells

  • Ka-Pan Lam
  • Yu-Te Chu
  • Chang-Hung Kuo
  • Wei-Li Wang
  • Teck-Siang Tok
  • Yow-Yue Chin
  • Solomon Chih-Cheng Chen
  • Chih-Hsing Hung
Article

DOI: 10.1007/s10753-010-9229-9

Cite this article as:
Lam, KP., Chu, YT., Kuo, CH. et al. Inflammation (2011) 34: 238. doi:10.1007/s10753-010-9229-9

Abstract

As indicated in the Global Initiative for Asthma guidelines, short-acting β2-adrenoreceptor agonists (SABAs) are important relievers in asthma exacerbation. Interferon γ-inducible protein (IP)-10/CXCL 10 is a T-helper type 1 (Th1) cell-related chemokine which is important in the recruitment of Th1 cells involved in host immune defense against intracellular pathogens such as viral infection. Regulated on activation, normal T expressed and secreted (RANTES)/CCL 5 is a chemokine which plays a role in attractant of eosinophils, mast cells, and basophils toward the site of allergic inflammation. Bronchial epithelial cells are first-line barriers against pathogen invasion. However, whether SABAs have regulatory effects on the expression of IP-10 and RANTES in bronchial epithelial cells is unknown. BEAS-2B cells, the human bronchial epithelial cell lines, were pretreated with procaterol (one of the SABAs) or dibutyryl-cAMP (a cyclic AMP analog) at different doses for 1 h and then stimulated with poly I:C (10 μg/mL). Supernatants were collected 12 and 24 h after poly I:C stimulation to determine the concentrations of IP-10 and RANTES by ELISA. In some cases, the cells were pretreated with selective β2-adrenoreceptor antagonist, ICI-118551, 30 min before procaterol treatment. To investigate the intracellular signaling, the cells were pretreated with mitogen-activated protein kinase (MAPK) inhibitors and a NF-κB inhibitor 30 min before procaterol treatment. Western blot was also used to explore the intracellular signaling. Procaterol significantly suppressed poly I:C-induced IP-10 and RANTES in BEAS-2B cells in a dose-dependent manner. ICI-118551, a selective β2-adrenoreceptor antagonist, could significantly reverse the suppressive effects. Dibutyryl-cAMP could confer the similar effects of procaterol on poly I:C-induced IP-10 and RANTES expression. Data of Western blot revealed that poly I:C-induced p-ERK, p-JNK, and pp38 expression, but not pp65, were suppressed by procaterol. SABAs could suppress poly I:C-induced IP-10 and RANTES expression in bronchial epithelial cells, at least in part, via β2-adrenoreceptor-cAMP and MAPK-ERK, JNK, and p38 pathways.

KEY WORDS

bronchial epithelial cells bronchodilators CXCL chemokines CCL chemokines short acting β2 agonist 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ka-Pan Lam
    • 1
    • 5
  • Yu-Te Chu
    • 2
    • 5
  • Chang-Hung Kuo
    • 2
    • 3
    • 4
    • 5
  • Wei-Li Wang
    • 2
    • 5
  • Teck-Siang Tok
    • 1
  • Yow-Yue Chin
    • 1
  • Solomon Chih-Cheng Chen
    • 1
  • Chih-Hsing Hung
    • 2
    • 3
    • 4
    • 5
  1. 1.Department of PediatricsPingtung Christian HospitalPingtungRepublic of China
  2. 2.Departments of PediatricsKaohsiung Medical University HospitalKaohsiungRepublic of China
  3. 3.Department of PediatricsKaohsiung Municipal Ta-Tung HospitalKaohsiungRepublic of China
  4. 4.Graduate Institute of Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungRepublic of China
  5. 5.Department of Pediatrics, Faculty of Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungRepublic of China

Personalised recommendations